Rankings
▼
Calendar
EWTX Q3 2025 Earnings — Edgewise Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
EWTX
Edgewise Therapeutics, Inc.
$3B
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$47M
Net Income
-$41M
EPS (Diluted)
$-0.39
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$35M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$583M
Total Liabilities
$25M
Stockholders' Equity
$559M
Cash & Equivalents
$46M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$47M
-$40M
-15.9%
Net Income
-$41M
-$34M
-19.2%
← FY 2025
All Quarters
Q4 2025 →